Atossa Therapeutics, Inc. (ATOS) has 18 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Guse Kyle 557,900 株保有. その他の主要保有者には Rees Heather および Chen Ben R.
過去12ヶ月間にインサイダーは 15 件の取引を実施 ATOS 株式 — 14 件の買い (評価額 $3.24M) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
ATOS インサイダー保有状況
最大保有者
Guse Kyle
557,900 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Guse Kyle |
CFO, Gen Counsel and Secretary |
557,900 |
2023-03-06 |
|
| 2 |
Rees Heather |
Chief Financial Officer |
543,785 |
2025-05-16 |
|
| 3 |
Chen Ben R |
Sr. VP of Glob. Reg. Affairs |
300,000 |
2014-04-03 |
|
| 4 |
Youmans Scott |
Chief Operating Officer |
286,217 |
2015-09-03 |
|
| 5 |
Remmel H. Lawrence |
Director |
125,000 |
2025-05-16 |
|
| 6 |
Steinhart Richard I |
Director |
125,000 |
2025-05-16 |
|
| 7 |
Cigler Tessa |
Director |
125,000 |
2025-05-16 |
|
| 8 |
Galli Stephen J |
Director |
125,000 |
2025-05-16 |
|
| 9 |
Chen Shu-chih |
Director |
125,000 |
2025-05-16 |
|
| 10 |
Finn Jonathan |
Director |
125,000 |
2025-05-16 |
|
| 11 |
Cross Alexander D |
Director |
88,866 |
2013-06-27 |
|
| 12 |
Quay Steven C |
President & CEO |
88,038 |
2026-03-31 |
|
| 13 |
Daniel Mark James |
Chief Financial Officer |
63,000 |
2026-03-30 |
|
| 14 |
Sawyer John E |
See Remarks |
59,265 |
2015-03-18 |
|
| 15 |
Destro Christopher S. |
SVP, Sales and Marketing |
54,625 |
2015-03-18 |
|
| 16 |
Carbonaro Peter J. |
Sr. Vice President, Operations |
45,000 |
2014-05-08 |
|
| 17 |
Barnhart John |
Director |
44,882 |
2013-05-09 |
|
| 18 |
Weaver Gregory L |
Former EVP, CFO, & Director |
55 |
2023-11-17 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-27 |
Quay Steven C |
President & CEO |
RSU 付与(制限付株式) |
65,000 |
- |
- |
| 2026-03-26 |
Daniel Mark James |
Chief Financial Officer |
RSU 付与(制限付株式) |
63,000 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
RSU 付与(制限付株式) |
331,674 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
RSU 付与(制限付株式) |
325,203 |
- |
- |
| 2025-10-14 |
Daniel Mark James |
Chief Financial Officer |
RSU 付与(制限付株式) |
578,000 |
$1.03 |
$595.34K |
| 2025-10-14 |
Daniel Mark James |
Officer |
不明 |
- |
- |
- |
| 2025-05-21 |
Quay Steven C |
President & CEO |
情報に基づく買い |
11,239 |
$0.88 |
$9.89K |
| 2025-05-15 |
Cigler Tessa |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Rees Heather |
Chief Financial Officer |
RSU 付与(制限付株式) |
543,785 |
$0.99 |
$538.35K |
| 2025-05-15 |
Finn Jonathan |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Chen Shu-chih |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Galli Stephen J |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Remmel H. Lawrence |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Quay Steven C |
President & CEO |
RSU 付与(制限付株式) |
1,366,062 |
$0.99 |
$1.35M |